Stay updated with breaking news from Erytech Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) was down 5.6% during mid-day trading on Friday . The stock traded as low as $1.04 and last traded at $1.10. Approximately 6,130 shares traded hands during trading, a decline of 99% from the average daily volume of 473,978 shares. The stock had previously closed at $1.17. The […]
ERYTECH Pharma S.A. (NASDAQ:ERYP – Get Rating) was the recipient of a significant decrease in short interest in the month of May. As of May 15th, there was short interest totalling 96,500 shares, a decrease of 84.4% from the April 30th total of 618,700 shares. Based on an average trading volume of 907,500 shares, the […]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Zacks Investment Research cut shares of ERYTECH Pharma (NASDAQ:ERYP – Get Rating) from a buy rating to a hold rating in a research note issued to investors on Monday morning, Zacks.com reports. According to Zacks, “Erytech Pharma S.A. operates as a biopharmaceutical company. It discovers and developes therapies for rare forms of cancer and orphan […]
Catalent, Inc. (NYSE:NYSE:CTLT) Q3 2022 Earnings Conference Call May 3, 2022 8:15 AM ET Company Participants Paul Surdez - Vice President, Investor Relations John Chiminski - Chair and...